Treatment of second degree facial burns with allografts - Preliminary results

Raymund E. Horch, Marc G. Jeschke, Gerald Spilker, David Herndon, Jürgen Kopp

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Facial burns are very common and have significant clinical impact. However, the treatment regimen for superficial to deep facial burns is not well defined. The purpose of this study was to investigate the effects of cadaver skin grafting in deep partial thickness facial burns in comparison to standard care. In a prospective open study design severely injured patients with superficial and deep partial thickness burns were randomized into the group receiving open treatment with silversulfadiazine (standard n = 5) or into the group receiving early superficial debridement followed by coverage with glycerolized cadaver skin (n = 5). The outcome measures were time and quality of wound healing, and incidence of hypertrophic scarring at 3 and 6 months post burn. There were no significant differences in demographics between groups. In the group treated with the allogenic material time to reepithelialization was 10.5 days, while it was 12.4 days in the silversulfadiazine group (p < 0.05). Scar quality was found to be significantly improved in the allogenic treatment group. Three and 6 months postburn there were no patients with significant hypertrophic scarring in the allogenic group while there were two patients who developed hypertrophic scars in the silversulfadiazine group (p < 0.05). In this study, we demonstrated that glyzerolized cadaver allograft skin represents a superior biological dressing for shallow and deep partial thickness facial burns. This is in concordance with other reports on scalds. It would be worthwhile to perform more clinical studies with a larger number of patients to further evaluate the effect and function of allogenic skin for facial burns.

Original languageEnglish (US)
Pages (from-to)597-602
Number of pages6
JournalBurns
Volume31
Issue number5
DOIs
StatePublished - Aug 2005

Fingerprint

Burns
Allografts
Cadaver
Cicatrix
Skin
Biological Dressings
Therapeutics
Hypertrophic Cicatrix
Skin Transplantation
Debridement
Wound Healing
Demography
Outcome Assessment (Health Care)
Prospective Studies
Incidence

Keywords

  • Allograft
  • Facial burns
  • Scar quality

ASJC Scopus subject areas

  • Emergency Medicine
  • Surgery

Cite this

Horch, R. E., Jeschke, M. G., Spilker, G., Herndon, D., & Kopp, J. (2005). Treatment of second degree facial burns with allografts - Preliminary results. Burns, 31(5), 597-602. https://doi.org/10.1016/j.burns.2005.01.011

Treatment of second degree facial burns with allografts - Preliminary results. / Horch, Raymund E.; Jeschke, Marc G.; Spilker, Gerald; Herndon, David; Kopp, Jürgen.

In: Burns, Vol. 31, No. 5, 08.2005, p. 597-602.

Research output: Contribution to journalArticle

Horch, RE, Jeschke, MG, Spilker, G, Herndon, D & Kopp, J 2005, 'Treatment of second degree facial burns with allografts - Preliminary results', Burns, vol. 31, no. 5, pp. 597-602. https://doi.org/10.1016/j.burns.2005.01.011
Horch, Raymund E. ; Jeschke, Marc G. ; Spilker, Gerald ; Herndon, David ; Kopp, Jürgen. / Treatment of second degree facial burns with allografts - Preliminary results. In: Burns. 2005 ; Vol. 31, No. 5. pp. 597-602.
@article{7ce8d841d4f54cb3bd50e1bd34367c50,
title = "Treatment of second degree facial burns with allografts - Preliminary results",
abstract = "Facial burns are very common and have significant clinical impact. However, the treatment regimen for superficial to deep facial burns is not well defined. The purpose of this study was to investigate the effects of cadaver skin grafting in deep partial thickness facial burns in comparison to standard care. In a prospective open study design severely injured patients with superficial and deep partial thickness burns were randomized into the group receiving open treatment with silversulfadiazine (standard n = 5) or into the group receiving early superficial debridement followed by coverage with glycerolized cadaver skin (n = 5). The outcome measures were time and quality of wound healing, and incidence of hypertrophic scarring at 3 and 6 months post burn. There were no significant differences in demographics between groups. In the group treated with the allogenic material time to reepithelialization was 10.5 days, while it was 12.4 days in the silversulfadiazine group (p < 0.05). Scar quality was found to be significantly improved in the allogenic treatment group. Three and 6 months postburn there were no patients with significant hypertrophic scarring in the allogenic group while there were two patients who developed hypertrophic scars in the silversulfadiazine group (p < 0.05). In this study, we demonstrated that glyzerolized cadaver allograft skin represents a superior biological dressing for shallow and deep partial thickness facial burns. This is in concordance with other reports on scalds. It would be worthwhile to perform more clinical studies with a larger number of patients to further evaluate the effect and function of allogenic skin for facial burns.",
keywords = "Allograft, Facial burns, Scar quality",
author = "Horch, {Raymund E.} and Jeschke, {Marc G.} and Gerald Spilker and David Herndon and J{\"u}rgen Kopp",
year = "2005",
month = "8",
doi = "10.1016/j.burns.2005.01.011",
language = "English (US)",
volume = "31",
pages = "597--602",
journal = "Burns",
issn = "0305-4179",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Treatment of second degree facial burns with allografts - Preliminary results

AU - Horch, Raymund E.

AU - Jeschke, Marc G.

AU - Spilker, Gerald

AU - Herndon, David

AU - Kopp, Jürgen

PY - 2005/8

Y1 - 2005/8

N2 - Facial burns are very common and have significant clinical impact. However, the treatment regimen for superficial to deep facial burns is not well defined. The purpose of this study was to investigate the effects of cadaver skin grafting in deep partial thickness facial burns in comparison to standard care. In a prospective open study design severely injured patients with superficial and deep partial thickness burns were randomized into the group receiving open treatment with silversulfadiazine (standard n = 5) or into the group receiving early superficial debridement followed by coverage with glycerolized cadaver skin (n = 5). The outcome measures were time and quality of wound healing, and incidence of hypertrophic scarring at 3 and 6 months post burn. There were no significant differences in demographics between groups. In the group treated with the allogenic material time to reepithelialization was 10.5 days, while it was 12.4 days in the silversulfadiazine group (p < 0.05). Scar quality was found to be significantly improved in the allogenic treatment group. Three and 6 months postburn there were no patients with significant hypertrophic scarring in the allogenic group while there were two patients who developed hypertrophic scars in the silversulfadiazine group (p < 0.05). In this study, we demonstrated that glyzerolized cadaver allograft skin represents a superior biological dressing for shallow and deep partial thickness facial burns. This is in concordance with other reports on scalds. It would be worthwhile to perform more clinical studies with a larger number of patients to further evaluate the effect and function of allogenic skin for facial burns.

AB - Facial burns are very common and have significant clinical impact. However, the treatment regimen for superficial to deep facial burns is not well defined. The purpose of this study was to investigate the effects of cadaver skin grafting in deep partial thickness facial burns in comparison to standard care. In a prospective open study design severely injured patients with superficial and deep partial thickness burns were randomized into the group receiving open treatment with silversulfadiazine (standard n = 5) or into the group receiving early superficial debridement followed by coverage with glycerolized cadaver skin (n = 5). The outcome measures were time and quality of wound healing, and incidence of hypertrophic scarring at 3 and 6 months post burn. There were no significant differences in demographics between groups. In the group treated with the allogenic material time to reepithelialization was 10.5 days, while it was 12.4 days in the silversulfadiazine group (p < 0.05). Scar quality was found to be significantly improved in the allogenic treatment group. Three and 6 months postburn there were no patients with significant hypertrophic scarring in the allogenic group while there were two patients who developed hypertrophic scars in the silversulfadiazine group (p < 0.05). In this study, we demonstrated that glyzerolized cadaver allograft skin represents a superior biological dressing for shallow and deep partial thickness facial burns. This is in concordance with other reports on scalds. It would be worthwhile to perform more clinical studies with a larger number of patients to further evaluate the effect and function of allogenic skin for facial burns.

KW - Allograft

KW - Facial burns

KW - Scar quality

UR - http://www.scopus.com/inward/record.url?scp=21344468636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344468636&partnerID=8YFLogxK

U2 - 10.1016/j.burns.2005.01.011

DO - 10.1016/j.burns.2005.01.011

M3 - Article

VL - 31

SP - 597

EP - 602

JO - Burns

JF - Burns

SN - 0305-4179

IS - 5

ER -